| scholarly article | Q13442814 |
| P50 | author | Liang-In Lin | Q56418529 |
| Chung-Yi Hu | Q59560211 | ||
| P2093 | author name string | Heng-An Liao | |
| Jeng-Wei Lu | |||
| Hsin-An Hou | |||
| Da-Liang Ou | |||
| Chien-Yuan Chen | |||
| An-Ni Wang | |||
| Hwei-Fan Tien | |||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | acute myeloid leukemia | Q264118 |
| P304 | page(s) | 218-225 | |
| P577 | publication date | 2016-04-06 | |
| P1433 | published in | Cancer Letters | Q326372 |
| P1476 | title | Cabozantinib is selectively cytotoxic in acute myeloid leukemia cells with FLT3-internal tandem duplication (FLT3-ITD) | |
| P478 | volume | 376 |
| Q30490446 | Association of a cytarabine chemosensitivity related gene expression signature with survival in cytogenetically normal acute myeloid leukemia |
| Q64107824 | Cytarabine-Resistant -ITD Leukemia Cells are Associated with Mutation and Multiple Pathway Alterations-Possible Therapeutic Efficacy of Cabozantinib |
| Q89595755 | Dual biomarkers long non-coding RNA GAS5 and its target, NR3C1, contribute to acute myeloid leukemia |
| Q59793942 | FLT3 inhibitors in acute myeloid leukemia |
| Q64107856 | Genetic polymorphisms of histone methyltransferase SETD2 predicts prognosis and chemotherapy response in Chinese acute myeloid leukemia patients |
| Q90137004 | Gilteritinib: a novel FLT3 inhibitor for acute myeloid leukemia |
| Q53636125 | Long non-coding RNA GAS5 polymorphism predicts a poor prognosis of acute myeloid leukemia in Chinese patients via affecting hematopoietic reconstitution. |
| Q92128519 | Targeting Tyrosine Kinases in Acute Myeloid Leukemia: Why, Who and How? |
| Q47345032 | The target landscape of clinical kinase drugs |
Search more.